… N-acetylaspartate:creatine ratio and SDMT with an r value of 0.39, although the correlation
with central atrophy was considerably larger (r = 0.70). Rovaris and colleagues 127 were the …

… Zivadinov received financial support for research activities from Biogen Idec, Teva
Pharmaceuticals, Sanofi-Genzyme, Bracco, Questcor Pharmaceuticals, and EMD Serono. Go to …

Over the past few years, MRI has become an indispensable tool for diagnosing multiple
sclerosis (MS). However, the current MRI criteria for MS diagnosis have imperfect sensitivity and …

Health-related quality of life (HQOL) is poor in multiple sclerosis (MS) but the clinical
precipitants of the problem are not well understood. Previous correlative studies demonstrated …

OBJECTIVE (a) To establish whether the cognitive decline of the early phase of relapsing-remitting
multiple sclerosis depends on the progression of the burden of disease, or on the …

… -up correlated with median new lesion volume in protected territories (r = −0.20275; R 2 …
was lower with SAPIEN 3 compared with Evolut R or SAPIEN XT. The overall treatment effect, …

Background: IV methylprednisolone (IVMP) has been used to treat relapses in patients with
relapsing-remitting (RR) MS, but its effect on disease progression is not known. Furthermore, …

… were both retained as SDMT predictors (R 2 = 0.35, p < 0.001), while for PASAT only
putamen was retained (R 2 … In the second tier, only putamen was retained both for SDMT (R 2 …

Sexual dysfunction is a very important but often overlooked symptom of multiple sclerosis.
To investigate the type and frequency of symptoms of sexual dysfunction in patient suffering …

… with all NP test results, with r values ranging from 0.29 (BVMT-R) to 0.58 (SDMT) (Figure 2).
… , Dwyer, and Zivadinov. Drafting of the manuscript: Benedict, Bruce, and Zivadinov. Critical …